The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 September 21, 2006
 Audio Icon Audio Summary
*
Correspondence
* Stimulatory Autoantibodies to the PDGF Receptor in Scleroderma
* ACE Inhibitors and Major Congenital Malformations
* Omalizumab for Asthma
* Obesity and Public Health Law
* Medical Mystery: Abnormal Chest Film — The Answer
* Positive Clostridium difficile Stool Assay in a Patient with Fatal C. sordellii Infection
*
Book Reviews
* Bipolar Psychopharmacotherapy: Caring for the Patient
* Depression and Brain Dysfunction
* Mind, Brain, and Schizophrenia
* Psychiatric Disorders in Pregnancy and the Postpartum: Principles and Treatment
Original Articles
Intracoronary Bone Marrow Cells in Acute Myocardial Infarction

To promote the regeneration of myocardial cells after myocardial infarction, intracoronary infusion of bone marrow cells, which contain stem cells and progenitor cells, has been investigated. In this study of patients with acute anterior myocardial infarction, infusion of bone marrow cells had no effect on left ventricular function or infarct size 6 months after the infarction.

Related Editorial


Original Articles
Intracoronary Progenitor Cells in Acute Myocardial Infarction

The infusion of bone marrow–derived progenitor cells into the infarct-related coronary artery after an acute myocardial infarction was associated with an absolute increase in the ejection fraction of 5.5%. Determining whether this modest improvement in ventricular function will translate into a long-term clinical benefit will require larger trials with longer follow-up.

Related Editorial


Original Articles
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction

Intracoronary infusion of progenitor cells derived from bone marrow in patients with healed myocardial infarction resulted in moderate but significant improvement in global and regional ventricular function. Circulating progenitor cells were less effective. The mechanisms underlying the benefit are uncertain. This line of research is in its early stages but may hold promise for the future.

Related Editorial


Original Articles
Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

In this randomized trial, eculizumab, a humanized monoclonal antibody against C5 that inhibits terminal complement activation, was compared with placebo as a treatment for paroxysmal nocturnal hemoglobinuria. The antibody stabilized hemoglobin levels, decreased the need for transfusions, and improved the quality of life by reducing intravascular hemolysis.


Clinical Practice
Acute Vulvovaginitis

A 24-year-old sexually active woman presents with a three-day history of vaginal pruritus and increased vaginal discharge. One year before presentation, she had the same symptoms, which resolved with use of an over-the-counter antifungal agent. She uses oral contraceptives for birth control. The physical examination reveals vulvar erythema and normal-appearing vaginal discharge. How should she be evaluated and treated?


Review Article
Mechanisms of Disease: Cancer Stem Cells

This review describes cancer stem cells, a topic of considerable biologic and clinical interest in oncology.


Case Records of the Massachusetts General Hospital
A Woman with Painful Nodules on the Fingertips, Shortness of Breath, and Fatigue

A 43-year-old woman was hospitalized because of painful nodules on the fingertips, shortness of breath, and fatigue. She had had systemic lupus erythematosus for 12 years, associated with Raynaud's phenomenon. Two weeks before admission, painful nodules developed on the fingers; 1 week later, shortness of breath and fatigue developed. On admission, computed tomography of the chest showed mediastinal and hilar lymphadenopathy and two nodules in the lung. A diagnostic procedure was performed.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.